GLP-1 medications have a well-established safety profile from large-scale clinical trials
AOD-9604 is not FDA-approved for any indication, and all use represents off-label application requiring informed medical decision-making
Around 62% of healthcare providers continue prescribing liraglutide due to its established safety profile and extensive clinical data spanning 10+ years
James Glutathione Injection has earned the prestigious FDA approval, a testament to its safety and efficacy
Higher time in range with combined therapy In a second presentation, Chantal Mathieu, MD, PhD, professor of medicine and chair of endocrinology at the University Hospital Gasthuisberg Leuven in Belgium, presented CGM data from the trial
Those taking anticoagulants should monitor carefully given the peptides effects on vascular systems